Rapid coronavirus test speeds up access to urgent care and will free up beds ahead of winter

• The SAMBA II diagnostic device cuts COVID-19 test result times from over 24 hours to just two hours.
• First “real-world” study of SAMBA devices on hospital wards finds patient time on COVID ‘holding wards’ was almost halved.
• Researchers say faster tests helped free up beds and expedite access to life-saving treatments such as organ transplants – and might make all the difference later this year.

Read more

To Prevent a Second Wave of COVID-19, AACC Calls on Senate to Include 5 Recommendations in Upcoming Coronavirus Bill

Now that the latest coronavirus relief package, known as the Heroes Act, has moved forward to the U.S. Senate, AACC has sent a letter to Senate leadership outlining five key recommendations that will improve COVID-19 testing capacity across the U.S. AACC urges the Senate to ensure these recommendations are addressed within the Heroes Act, as they are critical to preventing a second wave of the pandemic.

Read more

AACC Issues Recommendations on the Use of COVID-19 Antibody Tests

To ensure the proper use of antibody testing for the novel coronavirus, AACC today issued a public statement detailing the role these tests should play in the management of COVID-19 patients and in the development of public health policy. In particular, the organization emphasizes that healthcare professionals and policymakers should work closely with laboratory experts on antibody testing to ensure that these tests are validated, used appropriately, and interpreted correctly.

Read more

Not All FDA-Authorized COVID-19 Antibody Tests Are Equally Reliable

A first-of-its-kind study published today in AACC’s Clinical Chemistry journal compared the performance of two COVID-19 antibody tests and found that—even though both tests are FDA authorized—one produced more incorrect results than the other. These findings could help healthcare professionals and researchers to better select antibody tests, which are essential to both treating COVID-19 patients and determining the full extent of the outbreak.

Read more

AACC Launches Free Video Series to Help Explain COVID-19 Testing

To address some of the confusion surrounding COVID-19 testing, AACC today launched a video series in which leading laboratory experts answer common questions about tests for the pandemic. From persistent supply shortages to the emergence of antibody tests, these videos quickly answer the questions that patients and the general public have been asking.

Read more

Lab Experts Can Fill Gaps in FDA Regulation by Validating COVID-19 Antibody Tests

Now that diagnostic companies can sell COVID-19 antibody tests without FDA authorization, healthcare teams should work closely with clinical laboratory experts to ensure that these tests are thoroughly validated and used appropriately. A new opinion piece in AACC’s Clinical Chemistry journal emphasizes that this is critical to minimizing the risk of inaccurate results from these tests, which could have potentially life-threatening consequences.

Read more

AACC Commends Congress for Including Funding for Testing Improvements in the Latest Coronavirus Relief Package

AACC commends Congress for responding to the concerns of the clinical laboratory community and including $25 billion in the Paycheck Protection Program and Health Care Enhancement Act that is broadly marked for expanding the nation’s coronavirus testing capacity.

Read more

The Federal Government Must Act on Supply Chains to Enable COVID-19 Testing in High Volumes

With shortages of test components and swabs, labs still face huge obstacles to COVID-19 testing. With new White House guidelines reliant on more testing, AACC is urging the administration to find and coordinate resources so lab experts can do their jobs.

Read more